Kaposi Varicelliform Eruption Treatment & Management
- Author: Kerry A Lavigne, MD; Chief Editor: Dirk M Elston, MD more...
Medical Care
Antivirals are used in the treatment of Kaposi varicelliform eruption (KVE). See Medication.
Consultations
Consultation with an ophthalmologist is indicated when eye involvement is suspected. Herpetic keratitis can lead to scarring. Fortunately, ocular herpetic infection in the setting of Kaposi varicelliform eruption (KVE) is rare.
Beck LA, Boguniewicz M, Hata T, et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol. Aug 2009;124(2):260-9, 269.e1-7. [Medline].
Oyoshi MK, Elkhal A, Kumar L, et al. Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proc Natl Acad Sci U S A. Sep 1 2009;106(35):14954-9. [Medline]. [Full Text].
Howell MD, Gallo RL, Boguniewicz M, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity. Mar 2006;24(3):341-8. [Medline].
Kawakami Y, Tomimori Y, Yumoto K, et al. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med. Jun 8 2009;206(6):1219-25. [Medline]. [Full Text].
Howell MD, Wollenberg A, Gallo RL, et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol. Apr 2006;117(4):836-41. [Medline]. [Full Text].
Peng WM, Jenneck C, Bussmann C, et al. Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol. May 2007;127(5):1261-3. [Medline].
Kramer SC, Thomas CJ, Tyler WB, Elston DM. Kaposi's varicelliform eruption: a case report and review of the literature. Cutis. Feb 2004;73(2):115-22. [Medline].
Gao PS, Rafaels NM, Hand T, et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol. Sep 2009;124(3):507-13, 513.e1-7. [Medline].
Rinaldo CR Jr, Torpey DJ 3rd. Cell-mediated immunity and immunosuppression in herpes simplex virus infection. Immunodeficiency. 1993;5(1):33-90. [Medline].
Kawakami Y, Tomimori Y, Yumoto K, et al. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med. Jun 8 2009;206(6):1219-25. [Medline]. [Full Text].
Wheeler CE Jr, Abele DC. Eczema herpeticum, primary and recurrent. Arch Dermatol. Feb 1966;93(2):162-73. [Medline].
Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol. Aug 2003;49(2):198-205. [Medline].
Lubbe J, Sanchez-Politta S, Tschanz C, Saurat JH. Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention?. Arch Dermatol. May 2003;139(5):670-1. [Medline].
Yoshida M, Amatsu A. High frequency of detection of herpes simplex virus DNA in the oral cavity of patients with eczema herpeticum. Dermatology. 2004;209(2):101-3. [Medline].
Fivenson DP, Breneman DL, Wander AH. Kaposi's varicelliform eruption. Absence of ocular involvement. Arch Dermatol. Aug 1990;126(8):1037-9. [Medline].
Monsalvez V, Polo I, Fuertes L, Zarco C, Vanaclocha F. [Eczema herpeticum in cutaneous T-cell lymphomas]. Actas Dermosifiliogr. Jun 2009;100(5):431-3. [Medline].

